Tarceva With or Without Apatinib in the First-line Therapy of Advanced Lung Adenocarcinoma With Mutant EGFR:a Phase II Study
Latest Information Update: 16 Mar 2023
At a glance
- Drugs Erlotinib (Primary) ; Rivoceranib (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
Most Recent Events
- 14 Mar 2016 New trial record